Daily multidisciplinary COVID-19 meeting: Experiences from a French university hospital.

Aged Aged, 80 and over COVID-19 / therapy Clinical Decision-Making Female France Group Processes Hospitals, University Humans Male Medical Staff, Hospital Middle Aged Standard of Care
COVID-19 Multidisciplinary meetings Prospective cohorts Standard of care Therapeutic trials

Journal

Respiratory medicine and research
ISSN: 2590-0412
Titre abrégé: Respir Med Res
Pays: France
ID NLM: 101746324

Informations de publication

Date de publication:
May 2021
Historique:
received: 09 01 2021
revised: 23 04 2021
accepted: 27 04 2021
pubmed: 24 5 2021
medline: 23 6 2021
entrez: 23 5 2021
Statut: ppublish

Résumé

In March 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) a pandemic. In absence of official recommendations, implementing daily multidisciplinary team (MDT) COVID-19 meetings was urgently needed. Our aim was to describe our initial institutional standard operating procedures for implementing these meetings, and their impact on daily practice. All consecutive patients who were hospitalized in our institution due to COVID 19, from March 31 to April 15, 2020, were included. Criteria to be presented at MDT meetings were defined as a proven COVID-19 by PCR or strongly suspected on CT scan, requiring hospitalization and treatment not included in the standard of care. Three investigators identified the patients who met the predefined criteria and compared the treatment and outcomes of patients with predefined criteria that were presented during MDT meeting with those not presented during MDT meeting. COVID-19 MDT meeting implementation and adhesion were also assessed by a hospital medical staff survey. In all, 318 patients with confirmed or suspected COVID-19 were examined in our hospital. Of these, 230 (87%) were hospitalized in a COVID-19 unit, 91 (40%) of whom met predefined MDT meeting criteria. Fifty (55%) patients were presented at a MDT meeting versus 41 (45%) were not. Complementary exploration and inclusion in the CorImmuno cohort were higher in MDT meeting group (respectively 35 vs. 15%, P=0.03 and 80 versus 49%, P=0.0007). Prescription of hydrocortisone hemisuccinate was higher in group of patients not presented during MDT meeting (24 vs. 51%, P=0.007). Almost half of the patients fulfilling the inclusion criteria were not presented at MDT meeting, which can be partly explained by technical software issues. Multidisciplinary COVID-19 meetings helped implementing a single standard of care, avoided using treatments that were untested or currently being tested, and facilitated the inclusion of patients in prospective cohorts and therapeutic trials.

Identifiants

DOI: 10.1016/j.resmer.2021.100828 PMID: 34023794 PMC: PMC8103735
pubmed: 34023794
pii: S2590-0412(21)00017-9
doi: 10.1016/j.resmer.2021.100828
pmc: PMC8103735
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100828

Informations de copyright

Copyright © 2021 SPLF and Elsevier Masson SAS. All rights reserved.

Auteurs

C Rolland-Debord (C)

Service des explorations fonctionnelles de la respiration de l'exercice et de la dyspnée, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.

A Canellas (A)

Department of pneumology and thoracic oncology, centre constitutif maladies pulmonaires rares, hôpital Tenon, GRC n(o) 04, Theranoscan Sorbonne université, AP-HP, Paris, France.

P Choinier (P)

Department of pneumology and thoracic oncology, centre constitutif maladies pulmonaires rares, hôpital Tenon, GRC n(o) 04, Theranoscan Sorbonne université, AP-HP, Paris, France.

A Milon (A)

Department of radiology, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.

I Debrix (I)

Department of pharmacy, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.

E Blin (E)

Department of pneumology and thoracic oncology, centre constitutif maladies pulmonaires rares, hôpital Tenon, GRC n(o) 04, Theranoscan Sorbonne université, AP-HP, Paris, France.

N Belaube (N)

Department of infectious and tropical diseases, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.

S Mattioni (S)

Department of internal medicine, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.

F Millet (F)

Department of pneumology and thoracic oncology, centre constitutif maladies pulmonaires rares, hôpital Tenon, GRC n(o) 04, Theranoscan Sorbonne université, AP-HP, Paris, France.

M Nadal (M)

Department of infectious and tropical diseases, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.

C Petit-Hoang (C)

Department of nephrology, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.

P Rigaud (P)

Department of pneumology and thoracic oncology, centre constitutif maladies pulmonaires rares, hôpital Tenon, GRC n(o) 04, Theranoscan Sorbonne université, AP-HP, Paris, France.

J S Rech (JS)

Department of internal medicine, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.

M Siguier (M)

Department of infectious and tropical diseases, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.

D Sroussi (D)

Department of pneumology and thoracic oncology, centre constitutif maladies pulmonaires rares, hôpital Tenon, GRC n(o) 04, Theranoscan Sorbonne université, AP-HP, Paris, France.

M Denis (M)

Department of infectious and tropical diseases, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.

C Amiel (C)

Department of virology, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.

M Fartoukh (M)

Intensive care unit, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.

S Georgin-Lavialle (S)

Department of internal medicine, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.

L Lassel (L)

Department of infectious and tropical diseases, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.

A Parrot (A)

Department of pneumology and thoracic oncology, centre constitutif maladies pulmonaires rares, hôpital Tenon, GRC n(o) 04, Theranoscan Sorbonne université, AP-HP, Paris, France.

J Cadranel (J)

Department of pneumology and thoracic oncology, centre constitutif maladies pulmonaires rares, hôpital Tenon, GRC n(o) 04, Theranoscan Sorbonne université, AP-HP, Paris, France. Electronic address: jacques.cadranel@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Daily multidisciplinary COVID-19 meeting:...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Sujet âgé de 80 ans ou plus › Daily multidisciplinary COVID-19 meeting:...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Daily multidisciplinary COVID-19 meeting:...
questionsmedicales.fr › Diagnostic › Prise de décision clinique › Daily multidisciplinary COVID-19 meeting:...
questionsmedicales.fr › Régions géographiques › Europe › France › Daily multidisciplinary COVID-19 meeting:...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Processus de groupe › Daily multidisciplinary COVID-19 meeting:...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Établissements de santé › Hôpitaux › Hôpitaux d'enseignement › Hôpitaux universitaires › Daily multidisciplinary COVID-19 meeting:...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Daily multidisciplinary COVID-19 meeting:...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Personnel de santé › Personnel hospitalier › Personnel médical hospitalier › Daily multidisciplinary COVID-19 meeting:...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Daily multidisciplinary COVID-19 meeting:...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Norme de soins › Daily multidisciplinary COVID-19 meeting:...